PFIZER CEO: RECORDED FAVORABLE ADJUSTMENT TO REVENUES OF $771 MILLION FOR PAXLOVID, WHICH CONTRIBUTED 11 CENTS TO EPS IN Q1
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.56 USD | +0.11% | +0.63% | -0.80% |
May. 21 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
May. 21 | China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.80% | 162B | |
+37.78% | 723B | |
+32.82% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.64% | 244B | |
-4.13% | 208B | |
+10.63% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer Ceo: Recorded Favorable Adjustment To Revenues Of $771 M…